NIH Launches Database to Study COVID-19-Related Neurological Complications
MONDAY, Feb. 1, 2021 – The National Institutes of Health has launched a new database to collect information and biospecimens from people who have experienced neurological problems associated with severe acute respiratory syndrome coronavirus 2 infection.
The new database, COVID-19 Neuro Databank/Biobank (NeuroCOVID), will be maintained by NYU Langone Health in New York City. Health care providers are invited to use the web-based data portal to submit deidentified information into the database, along with relevant biospecimens collected during research studies or from previous clinical procedures and tests.
The database will collect information on COVID-19-related neurological symptoms, complications, and outcomes, as well as COVID-19 effects on preexisting neurological conditions. Researchers can access NeuroCOVID to study prevention, management, and treatment of neurological complications associated with COVID-19, while the database will hopefully provide insight into how COVID-19 affects the nervous system as well as how common or rare such complications are.
"The effects of the virus and the body's response to COVID-19 infection on the brain, spinal cord, nerves, and muscle can be particularly devastating, and contribute to persistence of disability even after the virus is cleared," Barbara Karp, M.D., program director at the National Institute of Neurological Disorders and Stroke, said in a statement. "There is an urgent need to understand COVID-19-related neurological problems, which not uncommonly include headaches, fatigue, cognitive difficulties, stroke, pain, and sleep disorders as well as some very rare complications of serious infections."
© 2021 HealthDay. All rights reserved.
Posted: February 2021
Further Support and Information on COVID-19
Read this next
Here is what the editors at Physician's Briefing chose as the most important COVID-19 developments for you and your practice for the week of March 1 to 5, 2021. This roundup...
FRIDAY, March 5, 2021 -- Countries worldwide are struggling to find enough syringes to administer COVID-19 vaccines. Experts say between 8 billion and 10 billion syringes are...
FRIDAY, March 5, 2021 -- Two cases of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant P.1 identified in Minnesota are described in a report published in...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.